Published on 9/29/2005 in the Prospect News Biotech Daily and Prospect News Convertibles Daily.
New Issue: Eksportfinans prices $655,000 notes linked to Pfizer
New York, Sept. 29 - Eksportfinans ASA priced $655,000 three-year auto-callable securities (Aces) linked to the common stock of Pfizer Inc., according to a 424B3 filing with the Securities and Exchange Commission.
| Issuer: | Eksportfinans ASA
|
| Issue: | Auto-callable securities (Aces) notes
|
| Underlying stock: | Pfizer Inc.
|
| Amount: | $655,000
|
| Maturity: | Oct. 3, 2008
|
| Coupon: | 0%
|
| Price: | 100
|
| Payout at maturity: | Par in cash if Pfizer stock closes at initial level or Pfizer stock closes below initial level and does not trade at or below knock-in level during term of notes; otherwise 40.323 Pfizer shares
|
| Initial level: | $24.80
|
| Knock-in level: | $19.84, 80% of initial level
|
| Exchange ratio: | 40.323
|
| Call: | Automatic redemption at 112.5% of par if Pfizer stock is above initial level on Sept. 27, 2006, at 125% of par if Pfizer stock is above initial level on Sept. 27, 2007, at 137.5% if Pfizer stock is above initial level on Sept. 26, 2008
|
| Pricing date: | Sept. 27
|
| Settlement date: | Sept. 30
|
| Underwriter: | Deutsche Bank
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
